![](https://ally-bridge.com/wp-content/uploads/2021/12/sonoma.jpg)
Sonoma Biotherapeutics
Sonoma Biotherapeutics focuses on Treg cell therapies for autoimmune and degenerative diseases. Using genome editing and target-specific cell therapy, the company works to discover and develop disease modifying and curative therapies across the spectrum of Treg cell therapeutic capabilities.